Authors
Latest:
Entering New Domains for 3D Printing of Drug Products3D printing of personalized medications is currently possible under existing compounding regulations, offering enhanced process control through automation. But new legislation coming in 2025 will allow 3D printing as part of a distributed manufacturing framework.
Latest:
The Role of Dry (Water-free) Process Equipment Cleaning in Continuous Pharmaceutical ManufacturingThe growing use of continuous manufacturing in the pharmaceutical industry merits a review of the application of dry cleaning and sanitization methods, especially for non-sterile oral solid drug product manufacturing of dry powders.
Latest:
EU GMP Annex 1 - Impact on Cleaning and DisinfectionAnnex 1 was released in 2022 and has had an impact on cleaning and disinfection. Download this article for more information on how your facility can stay compliant.
Latest:
Privacy and COVID-19 Clash, Creating Unprecedented Risks for PharmaTo maintain business continuity and employee safety during the pandemic, many companies have begun tracking and maintaining records of employee health information.
Latest:
Extending Shelf-Life With SorbentsExtending a drug product's shelf life while maintaining its strength, quality and purity is a challenge for pharma companies.
Latest:
Growing Opportunities in Outsourced Biopharma APIsConsistent growth in outsourced biomanufacturing points to an evolving industry increasingly reliant on external capacity and expertise.
Latest:
Data Integrity Considerations for Vendor-Generated Data Associated with Analytical TestingSponsors should consider best practices for maintaining data generated during sample analysis and instrument maintenance.
Latest:
Integrated Approach Facilitates Inhalation Drug DevelopmentThe choice of delivery platform for inhaled drug products is contingent on API-related factors, as well as the development stage of the product.
Latest:
Seven Trends Shaping the Future of Pharmaceutical Formulation DevelopmentEmerging new technologies and disruptive manufacturing concepts are providing new opportunities for pharmaceutical companies.
Latest:
Major Growth & Investment at Pace® Life SciencesDean Bornilla, Pace® Life Sciences, highlights his organization's future role in supporting biopharmaceutical development and manufacturing coast-to-coast.
Latest:
Overcoming The Challenges Of Cell-Based BioProcessingDiscussing the key challenges that face cell-based bioprocess manufacturers today, how these challenges might be addressed and the innovations that could facilitate the process in the future.
Latest:
Determining Low PPB Levels of Nitrite in Polymeric ExcipientsIn this paper, the authors introduce a method that combines ion exchange chromatography with an easier-to-perform, simpler one-step post-column derivatization that is selective to nitrite and visible spectrophotometric detection to allow high sample loading volumes without affecting resolution.
Latest:
Developing an Optimized Risk Assessment Portfolio—The Quality Risk Management Master PlanA thoughtfully constructed QRM Master Plan translates the strategy and enables a risk-based approach.
Latest:
Strategies to Simplify the Evaluation of Pharmaceutical Excipients***Wednesday, April 28, 2021, 8AM PDT | 11AM EDT | 4PM BST | 5PM CEST*** This webinar brings together experts from LGC and PerkinElmer to share their perspectives on addressing challenges in excipients testing, as well as providing insights and strategies for a successful path for the control of impurities in excipients to achieve 21 CFR Part 11 compliance.*** On demand available after final airing until April 28, 2022.***
Latest:
Dosage Form Compounding in the Workplace EnvironmentAn ordered pharmaceutical compounding process for use in 503A pharmacies, 503B outsourcing facilities, pharmaceutical industry, and other applications.
Latest:
Improving the Efficacy of Genetic MedicinesShawn Davis, CEO of Liberate Bio, shares some insights into the world of drug discovery, development, and delivery, as well as process optimization
Latest:
Blockchain and IoT: Determining ROI in the Pharma Supply ChainFor pharmaceutical manufacturers and their contract partners, blockchain and the Internet of Things promise to enable return on investment, not only by preventing counterfeiting and verifying returns but by enabling real-time condition monitoring and automating supply contracts.
Latest:
Data Integrity Considerations for Vendor-Generated Data Associated with Analytical TestingSponsors should consider best practices for maintaining data generated during sample analysis and instrument maintenance.
Latest:
The IKA CMX 2000Newest Innovation Of Solid-Liquid Mixers – Outstanding Powder Wetting In Batch Process
Latest:
Demystifying Systems Integrators and Automation Design Engineers: Understanding the DifferencesWhen you’re partnering with a design firm to support your product development and manufacturing needs through automation, it’s important to decide whether you should work with a systems integrator or an automation design engineering firm.
Latest:
Biosimilars: Is It Worth Taking On The Regulators?The different pathways to regulatory approval of a biosimilar vary worldwide, ranging from no pathways at all in some developing countries, to the complex and precise mechanism that exists in Europe.
Latest:
Extractable and Leachable Challenges in Lyophilized Drug ProductsThe authors examine the risks of extractables and leachables, and present solutions that emphasize the importance of a strategic, multi-prong approach.
Latest:
Addressing the Key Pitfalls Hindering Technology Transfer SuccessIn this article, the potential pitfalls of technology transfers are discussed as well as ways to ensure a smooth transition.
Latest:
Improving IR Spectroscopy as a Tool for Biopharmaceutical AnalysisA recent innovation in infrared spectroscopy, Microfluidic Modulation Spectroscopy has been shown to improve characterization of secondary protein structure.
Latest:
SMEDDS incorporated polymer matrix: A floating dosage form solution for drugs with poor gastric solubilityA new kind of gastro-retentive dosage form for drugs with poor aqueous solubility was developed and evaluated, with the aim of achieving gastro-retention.
